Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPublications section now states publications are automatically filled from PubMed, and the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page removed the banner noting a lapse in government funding and the NIH operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded related topics: Type 2 diabetes and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page content remains consistent with no significant changes to essential study information; only minor UI layout differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedThe 'Type 2 diabetes' condition label and related topics (MedlinePlus Genetics) were removed from the page.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the MedlinePlus Genetics topic on Type 2 diabetes, narrowing the genetics topics covered on the page.SummaryDifference0.3%

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.